Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc. (MGNX) Class Action – Shareholders Should Contact Robbins LLP for Information
11 sept. 2024 14h50 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
Robbins LLP Reminds MacroGenics, Inc. (MGNXX) Investors of the Class Action Lawsuit and Pending Lead Plaintiff Deadline
20 août 2024 16h47 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX
07 août 2024 16h31 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)
30 juil. 2024 22h18 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate